◆タイトル:Outsourcing Regulatory Market Affairs Report 2019-2029
◆商品コード:VGN910362
◆調査・発行会社:visiongain
◆発行日:2019年6月26日
◆ページ数:159
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。
【レポートの概要】
本調査レポートでは、"アウトソーシング規制の世界市場2019-2029"について調査・分析し、エグゼクティブサマリーなどの情報をお届けいたします。 |
Market Definition: • Sometimes the company own in-house workforce support is not ample to handle company expansion. To maintain that swiftness the company hires a skilled workforce from a third party firm, to set up them as per the company needs without hampering its current business. This process is known as outsourcing.
• Outsourcing can free up facilities and time resources which results in lower energy costs, taxes and reduction in production cost. Companies apply outsourcing strategies not only for cost saving but also to focus on its core business competencies.
• Regulatory affairs which is also known as government affairs, is a profession developed from the desire of governments to protect public health by managing the efficacy and safety of products in areas including veterinary medicines, pharmaceuticals, pesticides, agrochemicals, medical devices, complementary medicines and cosmetics, etc.
Market Overview and Trends
• The outsourcing of regulatory market affairs is on the rise. Outsourcing Regulatory Affairs activities to the Contract Research Organisations (CROs) offers cost efficiency, reduced regulatory submission time, and quality control in the overall manufacturing process. These factors are expected to give a rise to the outsourcing regulatory market.
• Regulatory Affairs Outsourcing market by manufacturer’s data helps the user to be familiar with the competitors. Manufacturer covers data including shipment, price, revenue, gross profit, interview record, business distribution and others. Regulatory Affairs Outsourcing market by manufacturer’s data helps the user to be familiar with the competitors. Manufacturer covers data including shipment, price, revenue, gross profit, interview record, business distribution and others.
• A major advantage of outsourcing is that companies can focus on their most important marketing authorisations and procedures such as product development processes which also are a reason for the growth of outsourcing regulatory market.
Market Dynamics:
Factors Influencing the Market Growth:
• The growth of the market is expected to increase by rise in R&D activities, especially in life science industry for the depletion in overall approval process by reducing delays in regulatory filings and the improvement in the Return on Investment (ROI) and cost efficiency.
• Outsourcing regulatory affairs activities exercises to the contract research organisations (CROs) propose cost efficiency; reduce regulatory submission time, and quality control in the manufacturing procedure. These elements drive the development of the market.
• Food and Drug Administration (FDA) has developed few digital programs such as a model for the digital health pre-certification program, policies for the multi-functional medical devices and internal data science incubator. The purpose of such initiatives is to utilise the potential of digital health tools in regulatory affairs to decrease the growing healthcare costs and patient risks.
Factors Restraining the Market Growth:
• The factors restraining the Outsourcing regulatory affairs market growth are Monitoring issues & lack of standardisation and Risk associated with data security.
Market Segmentation 2019-2029:
The Outsourcing regulatory affairs market is segmented on the service and region.
1. Outsourcing regulatory affairs, by Service
a) Regulatory consulting
b) Legal representation
c) Regulatory writing and publishing
d) Product registration and clinical trial application
e) Other regulatory service
2. Outsourcing regulatory affairs, by Region
a) North America
– US
– Canada
b) Europe
– Germany
– UK
– France
– Rest of Europe
c) Asia Pacific
– Japan
– China
– India
– Rest of Asia Pacific
d) Rest of the World (RoW)
Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the Global Biodefense market.
• These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.
Major Market Players:
PAREXEL International Corporation, IQVIA Holdings, Inc., Charles River Laboratories International, Inc., ICON plc, Covance, Inc., Genpact Limited, Intertek Group plc, Medpace, Inc., PRA Health Sciences, Inc., Syneos Health, Inc., Accell Clinical Research, LLC and other players.
1. Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Stakeholders
2. Research Methodology
2.1 Research Data
2.1.1 Primary Data
2.1.2 Secondary Data
2.2 Market Size Estimation
2.3 Research Assumptions
3. Executive Summary
4. Industry Insights
5. Outsourcing regulatory affairs market – By Service
5.1 Regulatory consulting
5.2 Legal representation
5.3 Regulatory writing and publishing
5.4 Product registration and clinical trial application
5.5 Other regulatory service
6. Outsourcing regulatory affairs market – By Region
6.1 North America
6.1.1 US
6.1.2 Canada
6.2 Europe
6.2.1 Germany
6.2.2 France
6.2.3 UK
6.2.4 Rest of Europe
6.3 Asia-Pacific
6.3.1 Japan
6.3.2 China
6.3.3 India
6.3.4 Rest of APAC
6.4 LAMEA
6.4.1 Latin America
6.4.2 Middle East
6.4.3 Africa
7. Competitive Landscape
8. Company Profiles
8.1 PAREXEL International Corporation
8.2 IQVIA Holdings, Inc.
8.3 Charles River Laboratories International, Inc.
8.4 ICON plc,
8.5 Covance, Inc.
8.6 Genpact Limited
8.7 Intertek Group plc, Medpace, Inc.
8.8 PRA Health Sciences, Inc.
8.9 Syneos Health, Inc.
8.10 Accell Clinical Research, LLC
8.11 Other players
List of Tables
Table 1 Global Outsourcing regulatory affairs Market Revenue Analysis & Forecast, By Service, (US$ Mn AGR%, CAGR%), 2019-2029
Table 2 Global Outsourcing regulatory affairs Market Revenue Analysis & Forecast, By Region, (US$ Mn AGR%, CAGR%), 2019-2029
Table 3 North America Outsourcing regulatory affairs Market Revenue Analysis & Forecast, By Service, (US$ Mn AGR%, CAGR%), 2019-2029
Table 4 U.S. Outsourcing regulatory affairs Market Revenue Analysis & Forecast, By Service, (US$ Mn AGR%, CAGR%), 2019-2029
Table 5 Canada Outsourcing regulatory affairs Market Revenue Analysis & Forecast, By Service, (US$ Mn AGR%, CAGR%), 2019-2029
Table 6 Europe Outsourcing regulatory affairs Market Revenue Analysis & Forecast, By Service, (US$ Mn AGR%, CAGR%), 2019-2029
Table 7 Germany Outsourcing regulatory affairs Market Revenue Analysis & Forecast, By Service, (US$ Mn AGR%, CAGR%), 2019-2029
Table 8 France Outsourcing regulatory affairs Market Revenue Analysis & Forecast, By Service, (US$ Mn AGR%, CAGR%), 2019-2029
Table 9 UK Outsourcing regulatory affairs Market Revenue Analysis & Forecast, By Service, (US$ Mn AGR%, CAGR%), 2019-2029
Table 10 Rest of Europe Outsourcing regulatory affairs Market Revenue Analysis & Forecast, By Service, (US$ Mn AGR%, CAGR%), 2019-2029
Table 11 Asia-Pacific Outsourcing regulatory affairs Market Revenue Analysis & Forecast, By Service, (US$ Mn AGR%, CAGR%), 2019-2029
Table 12 Japan Outsourcing regulatory affairs Market Revenue Analysis & Forecast, By Service, (US$ Mn AGR%, CAGR%), 2019-2029
Table 13 China Outsourcing regulatory affairs Market Revenue Analysis & Forecast, By Service, (US$ Mn AGR%, CAGR%), 2019-2029
Table 14 India Outsourcing regulatory affairs Market Revenue Analysis & Forecast, By Service, (US$ Mn AGR%, CAGR%), 2019-2029
Table 15 Rest of APAC Outsourcing regulatory affairs Market Revenue Analysis & Forecast, By Service, (US$ Mn AGR%, CAGR%), 2019-2029
Table 16 LAMEA Outsourcing regulatory affairs Market Revenue Analysis & Forecast, By Service, (US$ Mn AGR%, CAGR%), 2019-2029
Table 17 Latin America Outsourcing regulatory affairs Market Revenue Analysis & Forecast, By Service, (US$ Mn AGR%, CAGR%), 2019-2029
Table 18 Middle East Outsourcing regulatory affairs Market Revenue Analysis & Forecast, By Service, (US$ Mn AGR%, CAGR%), 2019-2029
Table 19 Africa Outsourcing regulatory affairs Market Revenue Analysis & Forecast, By Service, (US$ Mn AGR%, CAGR%), 2019-2029
List of Figures
Figure 1 Global Outsourcing regulatory affairs Market: Segmentation
Figure 2 Global Outsourcing regulatory affairs Market: Research Design
Figure 3 Global Outsourcing regulatory affairs Market: Figure 3 Drivers, Restraints, Opportunities, and Challenges
Figure 4 Global Outsourcing regulatory affairs Market: By Service
Figure 5 Global Outsourcing regulatory affairs Market: By Region
Figure 6 North America Outsourcing regulatory affairs Market: Market Snapshot
Figure 7 Europe Outsourcing regulatory affairs Market: Market Snapshot
Figure 8 Asia-Pacific Outsourcing regulatory affairs Market: Market Snapshot
Figure 9 LAMEA Outsourcing regulatory affairs Market: Market Snapshot
Figure 10 PAREXEL International Corporation: Financial Snapshot
Figure 11 IQVIA Holdings, Inc.: Financial Snapshot
Figure 12 Charles River Laboratories International, Inc.: Financial Snapshot
Figure 13 ICON plc: Financial Snapshot
Figure 14 Covance, Inc.: Financial Snapshot
Figure 15 Genpact Limited: Financial Snapshot
Figure 16 Intertek Group plc, Medpace, Inc.: Financial Snapshot
Figure 17 PRA Health Sciences, Inc.: Financial Snapshot
Figure 18 Syneos Health, Inc.: Financial Snapshot
Figure 19 Accell Clinical Research, LLC: Financial Snapshot